# U05 Aggregate Compatibility Re-Freeze Decision v0.1

> Decision ID: `AUTH-U05-AGR-REFREEZE-001`  
> Decision status: **REFREEZE / OWNER_APPROVED**  
> Reviewed amendment: PR #176  
> Exact reviewed amendment head: `f3a7823f2eb119b1103235a3e19d8e28f894b93d`  
> Targeted Compatibility Re-Review: **PASS** / review_id `5263853038`  
> This package authorizes no implementation, merge, production, downstream live execution, release activation, or real-patient traffic unless an explicit owner decision changes the re-freeze status only.

---

## 1. Decision question

Whether to re-freeze the reviewed U05 Aggregate Compatibility Amendment at exact head:

    f3a7823f2eb119b1103235a3e19d8e28f894b93d

covering only:

    BF-U05-AGR-01
    BF-U05-AGR-02
    BF-U05-AGR-03

and exactly these affected contracts:

    U05-RDP-01
    U05-RDP-02
    U05-RDP-03
    U05-RDP-05 status/provenance only
    U05-RDP-06

RDP-04 is unchanged.

---

## 2. Reviewed amendment result

Independent Compatibility Review:

    PR #176
    initial review
    = REVISE_REQUIRED
    review_id = 5263843388

Targeted Compatibility Re-Review:

    = PASS
    review_id = 5263853038

Final reviewed amendment status:

    BF-U05-AGR-01
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    BF-U05-AGR-02
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    BF-U05-AGR-03
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    BF-U05-AGR-AMEND-IR-01
    = CLOSED

    U05 Aggregate Compatibility Amendment
    = PASS / READY_FOR_EXPLICIT_REFREEZE_DECISION

---

## 3. What re-freeze would establish

If:

    AUTH-U05-AGR-REFREEZE-001 = REFREEZE

then the reviewed amendment becomes the current frozen/refrozen U05 compatibility baseline.

It would establish:

### AGR-01

    exact RESTRICTED U05 evaluation permission provenance
    is preserved through:

      inbound request
      -> admission result
      -> admitted input
      -> D03
      -> committed Clinical Readiness provenance

### AGR-02

    D03 explicitly binds:

      source_admission_ref
      source_readiness_input_set_identity

    and RDP-03 must verify equality before creating a readiness effect/proposal.

### AGR-03

    U05-RDP-05 current authoritative status
    = REFROZEN / V1

    historical PROPOSED status
    = superseded provenance only

### Verification

    RDP-06 can prove the above bindings using explicit structured evidence.

---

## 4. What re-freeze would NOT establish

Re-freeze does NOT mean:

    U05 code implemented

    U05 implementation verification executed

    U05 Implementation Readiness automatically READY

    U05 Implementation Authorization granted

    Scheduler live execution authorized

    U06/U08/U10/U11 live invocation authorized

    production Clinical State mutation authorized

    merge authorized

    production Clinical Runtime authorized

    release activation authorized

    real-patient traffic authorized

After re-freeze the required next step is still:

    U05 Implementation Readiness Re-Evaluation

against the exact re-frozen six-contract package.

---

## 5. Semantic invariants preserved

The reviewed amendment does not change:

    six Clinical Readiness values

    D03 runtime status vocabulary

    P0-P7 precedence

    D03-POL-005

    D03-POL-011

    RDP-05 applicability meanings

    F1/F3/F5/F6 owner boundaries

    K09/P01 ownership

    RDP-04 readiness-to-target mapping

    downstream action permission ownership

    U14 failure ownership

    non-production no-live-downstream boundary

---

## 6. Exact file scope

Re-freeze scope is limited to the reviewed semantic diff in PR #176.

Allowed affected files:

1. `docs/current/06_开发单元/U05_RDP01_Consumer_Inbound_Contract_v0.1.md`
2. `docs/current/06_开发单元/U05_RDP02_D03_Policy_Owner_Decision_Contract_v0.1.md`
3. `docs/current/06_开发单元/U05_RDP03_State_Ownership_K09_P01_Mutation_Trace_Contract_v0.1.md`
4. `docs/current/06_开发单元/U05_RDP05_Readiness_Input_Dependency_Applicability_Contract_v0.1.md`
5. `docs/current/06_开发单元/U05_RDP06_Verification_Durable_Evidence_Plan_v0.1.md`

No other frozen artifact is included in this decision.

If an additional semantic artifact is found necessary:

    STOP
    -> do not re-freeze under this decision
    -> return to compatibility amendment review

---

## 7. Decision options

Owner may choose exactly one:

    REFREEZE

    REVISE

    REJECT

### REFREEZE

Authorizes only:

    re-freeze status/provenance synchronization
    for the exact reviewed amendment head

and permits the next:

    U05 Implementation Readiness Re-Evaluation

### REVISE

Requires another compatibility amendment/review cycle.

### REJECT

Keeps the previous frozen baseline and the aggregate blockers remain open.

---

## 8. Current state

Owner decision:

    AUTH-U05-AGR-REFREEZE-001
    = REFREEZE

    Owner command
    = REFREEZE

    Decision applies only to exact reviewed amendment head:
      f3a7823f2eb119b1103235a3e19d8e28f894b93d

    BF-U05-AGR-01
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    BF-U05-AGR-02
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    BF-U05-AGR-03
    = REMEDIATED / AMENDMENT_REVIEW_PASS / REFREEZE_PENDING

    U05 Implementation Readiness
    = NOT_READY

    U05 Implementation Authorization Review
    = NOT_PERMITTED_YET

    U05 Implementation Authorization
    = NOT_GRANTED


---

## 9. Owner Re-Freeze Decision Record

Owner decision:

    REFREEZE

Authorization ID:

    AUTH-U05-AGR-REFREEZE-001
    = GRANTED_FOR_REFREEZE_ONLY

Authorized exact reviewed amendment head:

    f3a7823f2eb119b1103235a3e19d8e28f894b93d

Independent gate basis:

    PR #177
    Gate Review = PASS
    review_id = 5263862081

Authorized action:

    synchronize re-freeze status/provenance
    for the five reviewed amended contracts only

Required post-action verification:

    prove status/provenance-only diff
    against the reviewed semantic head

    then repeat:
      U05 Implementation Readiness Re-Evaluation

Explicitly not authorized:

    runtime/code implementation
    merge
    live Scheduler/downstream execution
    production mutation
    production Clinical Runtime
    release activation
    real-patient traffic
